Suchergebnisse - "9NDF7JZ4M3"

PubPharm (4.971)

81

Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism

enthalten in: Thrombosis research | 2024

von Rueda-Camino, J. | Barba, R. | Otálora, S. | +9

82

Effect of factor XI inhibition on tumor cell-induced coagulation activation

enthalten in: Journal of thrombosis and haemostasis : JTH | 2024

von Mäder, J. | Rolling, C. | Voigtländer, M. | +6

83

Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction : a network meta-analysis

enthalten in: The Cochrane database of systematic reviews | 2024

von Al Said, S. | Kaier, K. | Sumaya, W. | +6

84

Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2024

von Yu, Y. | Li, H. | Liu, J. | +3

85

Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation

enthalten in: PloS one | 2024

von Limcharoen, S. | Limprasert, S. | Boonmuang, P. | +5

86

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada

enthalten in: PharmacoEconomics | 2024

von Hafeez, A. | Cipriano, L. | Kim, R. | +3

87

Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation : a cross-sectional study

enthalten in: Drugs & aging | 2024

von Decaix, T. | Kemache, K. | Gay, P. | +3

ErratumIn: Drugs Aging. 2023 Dec 21;:. - PMID 38127166

88

Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation

enthalten in: Pharmacoepidemiology and drug safety | 2024

von Álvaro Thomsen, T. | Mesa Guadalupe, J. | Huerta, C. | +2

89

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study

enthalten in: European heart journal. Quality of care & clinical outcomes | 2024

von Grymonprez, M. | Petrovic, M. | De Backer, T. | +2

90

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries

enthalten in: PloS one | 2024

von Ruigómez, A. | Schink, T. | Voss, A. | +7